{"id":228348,"date":"2026-01-05T01:07:41","date_gmt":"2026-01-05T07:07:41","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/01\/glucagonlike-peptide-1-receptor-agonists-and-asthma-risk-in-adolescents-with-obesity"},"modified":"2026-01-05T01:07:41","modified_gmt":"2026-01-05T07:07:41","slug":"glucagonlike-peptide-1-receptor-agonists-and-asthma-risk-in-adolescents-with-obesity","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/01\/glucagonlike-peptide-1-receptor-agonists-and-asthma-risk-in-adolescents-with-obesity","title":{"rendered":"Glucagonlike Peptide-1 Receptor Agonists and Asthma Risk in Adolescents With Obesity"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/glucagonlike-peptide-1-receptor-agonists-and-asthma-risk-in-adolescents-with-obesity2.png\"><\/a><\/p>\n<p>This retrospective cohort study reported an association between GLP1RA use and a lower risk of acute asthma exacerbations in adolescents with overweight or obesity, suggesting a potential dual benefit for this population.<\/p>\n<hr>\n<p>This cohort study investigates the association between glucagonlike peptide-1 receptor agonist use and the risk of acute asthma exacerbations among adolescents with overweight or obesity and asthma.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This retrospective cohort study reported an association between GLP1RA use and a lower risk of acute asthma exacerbations in adolescents with overweight or obesity, suggesting a potential dual benefit for this population. This cohort study investigates the association between glucagonlike peptide-1 receptor agonist use and the risk of acute asthma exacerbations among adolescents with overweight [\u2026]<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-228348","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228348","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=228348"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/228348\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=228348"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=228348"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=228348"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}